Health Highlights: April 12, 2022

New Drug Halves Death Rate in Those With Severe COVID, Maker Claims: An experimental medication for critically ill COVID patients has worked so well that the drug's maker announced Monday it has stopped its clinical trial early and will apply for emergency use authorization. Read more
Philadelphia Becomes First US City to Bring Back Mask Mandate: Faced with rising COVID-19 case counts, the city announced Monday that it will reinstate an indoor mask mandate next week. Read more
Study Finds Just One Dose of HPV Vaccine May be Enough: A single shot provided as much protection against cervical cancer as the standard three-dose regimen, a finding that researchers say could be a game-changer in efforts to vaccinate more people against the human papillomavirus. Read more
Could Some Rheumatoid Arthritis Meds Help Lower Alzheimer's Risk? Preliminary findings suggest a class of rheumatoid arthritis drugs known as TNF inhibitors may lower dementia risk in rheumatoid arthritis patients who also suffer from heart disease. Read more
Related Posts
Survivors of Severe COVID Face Doubled Risk for Death a Year Later
THURSDAY, Dec. 2, 2021 (HealthDay News) -- People who recovered from a severe...
Levantar cualquier tipo de pesas ayuda a desarrollar el músculo
VIERNES, 14 de julio de 2023 (HealthDay News) -- Levantar pesas de forma regular...
Injected Diabetes Med Can Also Bring Big Weight Loss, Study Finds
THURSDAY, April 27, 2023 (HealthDay News) -- As more Americans attempt to get...
Salmonella Infections in 6 States Linked to Papa Murphy’s Raw Cookie Dough
WEDNESDAY, May 24, 2023 (HealthDay News) – The U.S. Centers for Disease Control...
